Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus

Annals of the Rheumatic Diseases

Volumn 68, Issue 6, 2009, Pages 828-835

  Rivera, T L ^a   Izmirly, P M ^a   Birnbaum, B K ^b   Byrne, P ^a   Brauth, J B ^a   Katholi, M ^a   Kim, M Y ^c   Fischer, J ^c   Clancy, R M ^a   Buyon, J P ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BIOLOGICAL MARKER; INTERLEUKIN 1ALPHA; RO ANTIBODY; RO ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CESAREAN SECTION; DISEASE COURSE; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MEDICAL INFORMATION SYSTEM; MEDICAL RECORD; MOTHER; NEWBORN; NEWBORN DISEASE; PRIORITY JOURNAL; REGISTER; RELIABILITY; SJOEGREN SYNDROME; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOTHERS; POLYMORPHISM, GENETIC; REGISTRIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67449133557     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.088054     Document Type: Article

References (35)

1. Izmirly PM, Rivera TL, Buyon, JP. Neonatal lupus syndromes. Rheum Dis Clin North Am 2007;33:267-285 (Pubitemid 46710331)
2. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658-1666 (Pubitemid 28273312)
3. Julkunen H, Eronen M. The rate of recurrence of isolated congenital heart block: a population-based study. Arthritis Rheum 2001;44:487-488
4. McCune AB, Weston WL, Lee LA. Maternal and fetal outcome in neonatal lupus erythematosus. Ann Intern Med 1987;106:518-523 (Pubitemid 17095035)
5. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-1533 (Pubitemid 37255038)
6. Clancy RM, Backer CB, Yin X, Chang MW, Cohen SR, Lee LA, et al. Genetic association of cutaneous neonatal lupus with HLA class II and tumor necrosis factor alpha: implications for pathogenesis. Arthritis Rheum 2004;50:2598-2603 (Pubitemid 39062721)
7. Clancy RM, Backer CB, Kapur RP, Yin X, Molad Y, Buyon JP. Cytokine polymorphisms and histologic expression in autopsy studies: contribution of tumor necrosis factor-α and transforming growth factor-β1 to the pathogenesis of autoimmune-associated congenital heart block. J Immunol 2003;171:3253-3261 (Pubitemid 37093552)
8. Parks CG, Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, et al. Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States. Ann Rheum Dis 2004;63:91-94 (Pubitemid 38064611)
9. Parks CG, Pandey JP, Dooley MA, Treadwell EL, St Clair EW, Gilkenson GS, et al. Genetic polymorphisms in tumor necrosis factor (TNF)-α and TNF-β in a population-based study of systemic lupus erythematosus: associations and intereaction with the interleukin-1 α-889 C/T polymorphism. Hum Immunol 2004;65:622-631 (Pubitemid 38813413)
10. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-558 (Pubitemid 34539104)
11. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277 (Pubitemid 13221242)
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
13. Tseng CE, Chan EK, Miranda E, Gross M, Di Donato F, Buyon JP. The 52-kd protein as a target of intermolecular spreading of the immune response to components of the SS-A/Ro-SS-B/La complex. Arthritis Rheum 1997;40:936-944 (Pubitemid 27200012)
14. Clancy RM, Buyon JP, Ikeda K, Nozawa K, Argyle DA, Friedman DM, et al. Maternal antibody responses to the 52-kd SSA/Ro p200 peptide and the development of fetal conduction defects. Arthritis Rheum 2005;52:3079-3086 (Pubitemid 41447089)
15. Neiman AR, Lee LA, Weston WL, Buyon JP. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J Pediatr 2000;137:674-680 (Pubitemid 30840126)
16. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994;120:544-551 (Pubitemid 24091594)
17. Martin V, Lee LA, Askanase AD, Katholi M, Buyon JP. Long-term followup of children with neonatal lupus and their unaffected siblings. Arthritis Rheum 2002;46:2377-2383
18. Buyon JP. The heart and skin of neonatal lupus: does maternal health matter? Am J Med 2000;108:741-743
19. Lawrence S, Luy L, Laxer R, Krafchik B, Silverman E. The health of mothers of children with cutaneous neonatal lupus erythematosus differs from that of mothers of children with congenital heart block. Am J Med 2000;108:705-709 (Pubitemid 30621457)
20. Julkunen H, Kurki P, Kaaja R, Heikkila R, Immonen I, Chan EK, et al. Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La. Arthritis Rheum 1993;36:1588-1598
21. Julkunen H, Eronen M. Long-term outcome of mothers of children with isolated heart block in Finland. Arthritis Rheum 2001;44:647-652 (Pubitemid 32234623)
22. Press J, Uziel Y, Laxer RM, Luy L, Hamilton RM, Silverman ED. Long-term outcome of mothers of children with complete congenital heart block. Am J Med 1996;100:328-332
23. Tseng C, Di Donato F, Buyon JP. Stability of immunoblot profile of anti-SSA/Ro-SSB/ La antibodies over time in mothers whose children have neonatal lupus. Lupus 1996;5:212-215 (Pubitemid 26197479)
24. Salmonsson S, Dörner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius M. A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 2002;46:1233-1241 (Pubitemid 34525831)
25. Vilá LM, Mayor AM, Valentín AH, García-Soberal M, Vilá S. Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus 2000;9:110-115 (Pubitemid 30171107)
26. Swaak AJ, van de Brink H, Smeenk RJ, Manger K, Kalden JR, Tosi S, et al. Incomplete lupus erythematosus: results of a multicenter study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). Rheumatology (Oxford) 2001;40:89-94. (Pubitemid 32124053)
27. Cavazzana I, Franceschini F, Belfiore N, Quinzanini M, Caporali R, Calzavara-Pinton P, et al. Undifferentiated connective tissue disease with antibodies to Ro/SSa: clinical features and follow-up of 148 patients. Clin Exp Rheumatol 2001;19:403-409 (Pubitemid 32685366)
28. Stahl Hallengren C, Nived O, Sturfelt G. Outcome of incomplete systemic lupus erythematosus after 10 years. Lupus 2004;13:85-88 (Pubitemid 38222351)
29. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-β1 gene: association with transforming growth factor-β1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998;66:1014-1020 (Pubitemid 28513380)
30. Hinke V, Seck T, Clanget C, Scheidt-Nave C, Ziegler R, Pfeilschifter J. Association of transforming growth factor-β1 (TGFβ1) T29 → C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-β1 in a population-based sample of postmenopausal German women. Calcif Tissue Int 2001;69:315-320
31. Hubacek JA, Weichetova M, Bohuslavova R, Skodova Z, Adamkova V, Stepan JJ. Genetic polymorphisms of TGF-β, PAI-1, and COL1A-1, and determination of bone mineral density in Caucasian females. Endocr Regul 2006;40:77-81. (Pubitemid 44788373)
32. Brazova J, Sismova K, Vavrova V, Bartosova J, Macek M Jr, Lauschman H, et al. Polymorphisms of TGF-β1 in cystic fibrosis patients. Clin Immunol 2006;121:350-357 (Pubitemid 44738719)
33. Ziv E, Kahn A, Cauley J, Morin P, Saiz R, Browner W. No association between the TGF-β 1 Leu10Pro polymorphism and osteoporosis among white women in the United States. Am J Med 2003;114:227-231 (Pubitemid 36294010)
34. Wang B, Morinobu A, Kanagawa S, Koshiba M, Hashimoto, H, Kumagai S. Transforming growth factor beta 1 gene polymorphism in Japanese patients with systemic lupus erythematosus. Kobe J Med Sci 2007;53:15-23. (Pubitemid 46651012)
35. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006;24:99-146.